Efficacy of Quetiapine in Generalised Social Anxiety Disorder

Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study

This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with the LSAS

Inclusion Criteria:

• Written Confirmed Consent,
• All patients meet the DSM IV criteria for generalized social anxiety disorder,
• A score ≥ 60 on the LSAS,
• male and female aged between 18 and 65 years

Exclusion Criteria:

• Presence of any primary axis I diagnosis other than social anxiety disorder according to DSM-IV,
• alcohol and/or substance abuse according to DSM-IV criteria within the last 12 months,
• any personality disorder as the primary diagnosis, with the exception of avoidant personality disorder,
• patients at risk of suicide